Molecular characterization of a novel cancer cell line established from human carcinoma in pleomorphic adenoma (CaPA-4)

International Journal of Cancer

Volumn 67, Issue 2, 1996, Pages 204-210

  Fujioka, Manabu ^a   Shimada, Kei Kichi ^a   Kitazawa, Sohei ^a   Maeda, Sakan ^a  

^a KOBE UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC G 418;

ARTICLE; CELL DIFFERENTIATION; CHROMOSOME ANALYSIS; GENE ACTIVATION; GENE AMPLIFICATION; GENE EXPRESSION; GENE REARRANGEMENT; HUMAN; HUMAN CELL; MALIGNANT TRANSFORMATION; ONCOGENE C MYC; PLEOMORPHIC ADENOMA; POINT MUTATION; PRIORITY JOURNAL; SUBMANDIBULAR GLAND; XENOGRAFT;

ADENOMA, PLEOMORPHIC; ANIMALS; BASE SEQUENCE; CELL DIVISION; FIBROBLASTS; GENE EXPRESSION; GENES, MYC; GENES, P53; GENES, RAS; GENTAMICINS; HUMANS; MICE; MICE, NUDE; MICROSCOPY, ELECTRON; NEOPLASM TRANSPLANTATION; POINT MUTATION; SUBMANDIBULAR GLAND NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 0029812086     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19960717)67:2<204::AID-IJC10>3.0.CO;2-B     Document Type: Article

References (43)

1. ALEXANDER, J.J., BEY, E.M., WHITCUTT, J.M. and GEAR, J.H.S., Adaptation of cells derived from human malignant tumors to growth in vitro. S. Afr. J. med. Sci., 41, 89-98 (1976).
2. AZUMA, M., KASAI, Y., TAMATANI, T. and SATO, M., Involvement of p53 mutation in the development of human salivary-gland pleomorphic adenomas. Cancer Lett., 65, 61-71 (1992).
3. BAKER, S.J., PREISINGER, A.C., JESSUP, J.M., PARASKEVA, C., MARKOWITZ, S., WILLSON, J.K.V., HAMILTON, S. and VOGELSTEIN, B., p53 gene mutations occur in combination with 17p allelic deletion as late events in colorectal tumorigenesis. Cancer Res., 50, 7717-7722 (1990).
4. BALMAIN, A. and BROWN, K., Oncogene activation in chemical carcinogenesis. Advanc. Cancer Res., 51, 147-182 (1988).
5. BARBACID, M., Ras genes. Ann. Rev. Biochem., 56, 779-827 (1986).
6. BARDI, G., PANDIS, N., FENGER, C., KRONBORG, O., BOMME, L. and HEIM, S.H., Deletion of 1p36 as a primary chromosomal aberration in intestinal tumorigenesis. Cancer Res., 53, 1895-1898 (1993).
7. CHAUVEL, D., DEMARD, F., GIOANNI, J., COURDI, A., PHILIP, C. and ANNE, C.M., Establishment and characteristics of two cell lines derived from cancers of the oral cavity. (Abstract). Presented at International Conference of Head and Neck Cancer, Baltimore, MD, July 22-27, 1984. Vol. 120, (1984).
8. CHEN, L.-C., DOLLBAUM, C. and SMITH, H.S., Loss of heterozygosity on chromosome 1q in human breast cancer. Proc. nat. Acad. Sci. (Wash.), 86, 7204-7207 (1989).
9. EASTY, D.M., EASTY, D.C., CARTER, R.L., MONAGHAN, P. and BUTLER, L.J., Ten human carcinoma cell lines derived from squamous carcinomas of the head and neck. Brit. J. Cancer, 43, 772-785 (1981).
10. FEARON, E.R., FEINBERG, A.P., HAMILTON, S.H. and VOGELSTEIN, B., Loss of genes on the short arm of chromosome 11 in bladder cancer. Nature (Lond.), 318, 377-380 (1985).
11. FUJIMORI, T., SATONAKA, K., YAMAMURA-IDEI, Y., NAGASAKO, K. and MAEDA, S., Non-involvement of ras mutations in flat colorectal adenomas and carcinomas. Int. J. Cancer, 57, 51-55 (1994).
12. FUJITA, J., SRIVASTAVA, S.K., KRAUS, M.H., RHIM, J.S., TRONICH, S.R. and AARONSON, S.A., Frequency of molecular alterations affecting ras protooncogenes in human urinary tract tumors. Proc. nat. Acad. Sci. (Wash.), 82, 3849-3853 (1985).
13. FUJITA, J., YOSHIDA, O., YUASA, Y., RHIM, J.S., HATANAKA, M. and AARONSON, S.A., Ha-ras oncogenes are activated by somatic mutations in human urinary tract tumors. Nature (Lond.), 309, 464-466 (1984).
14. GOTOH, M., NAKAJIMA, T., YOKATA, J., TSUNOKAWA, Y., TERADA, M., SHIMOYAMA, Y., TESHIMA, S., HIROHASHI, S. and SHIMOSATO, Y., Newly established uterine-carcinoma cell line with co-amplification of human papilloma-virus DNA and c-myc gene. Jap. J. Cancer Res., 82, 1252-1257 (1991).
15. HALABAN, R. and ALFANO, F.D., Selective elimination of fibroblasts from cultures of normal human melanocytes. In Vitro, 20, 447-450 (1984).
16. HALL, A., MARSHALL, C.J., SPURR, N.K. and WEISS, R.A., Identification of transforming gene in two human sarcoma cell lines as a new member of the ras gene family located on chromosome 1. Nature (Lond.), 303, 396-400 (1983).
17. HAUSER-URFER, I.H. and STAUFFER, J., Comparative chromosome analysis of nine squamous-cell carcinoma cell lines from tumors of the head and neck. Cytogenet. Cell Genet., 39, 35-39 (1985).
18. HAYASHI, K., KAKIZOE, T. and SUGIMURA, T., In vivo amplification and rearrangement of the c-Ha-ras-1 sequence in a human bladder carcinoma. Gann, 74, 798-801 (1983).
19. HAYASHI, E., RIKIMARU, K., SATOMURA, K., NAKANO, K., HOTEIYA, T., KURASATO, T. and NAGAYAMA, M., Establishment and characterization of four human oral cancer cell lines. J. Jap. stomatol. Soc., 44, 47-54 (1995).
20. HOLLSTEIN, M., METCALF, R.A., WELSH, J.A., MONTESANO, R. and HARRIS, C.C., Frequent mutation of the p53 gene in human esophageal cancer. Proc. nat. Acad. Sci. (Wash.), 87, 9958-9961 (1990).
21. INAGAKI, T., MATSUWARI, S., TAKAHASHI, R., SHIMADA, K., FUJIE, K. and MAEDA, S., Establishment of human oral cancer cell lines (KOSC-2 and 3) carrying p53 and c-myc abnormalities by geneticin treatment. Int. J. Cancer, 56, 301-308 (1994).
22. KLEIN, G. and KLEIN, E., Evolution of tumors and their impact on molecular oncology. Nature (Lond.), 315, 190-195 (1985).
23. LEBEAU, M.M., WESTBROOK, C.A. and DIAZ, M.O., Evidence for two distinct c-src loci on human chromosomes 1 and 20. Nature (Lond.), 312, 70-71 (1984).
24. LOSI, L., BENHATTAR, J. and COSTA, J., Stability of K-ras mutations throughout the natural history of human colorectal cancer. Europ. J. Cancer, 28A, 1115-1120 (1992).
25. MARINA, I.G., KISHOR, B., DAVID, S., LINDA, W., IAN, T.M., FREDERIC, M. and KONRAD, H., Infrequent p53 mutation in mouse tumors with de-regulated myc. Cancer Res., 52, 1032-1035 (1992).
26. MARK, J., DAHLENFORS, R. and EKEDAHL, C., The mixed salivary gland tumor - a normal benign human neoplasm frequently showing specific chromosomal abnormalities. Cancer Genet. Cytogenet., 2, 231-241 (1980).
27. MERRITT, W.D., WEISSLER, M.C., TURK, B.F. and GILMER, T.M., Oncogene amplification in squamous cell carcinoma of the head and neck. Arch. Otolaryngol. Head Neck Surg., 116, 1394-1398 (1990).
28. MURAKAMI, H., MASUI, H. and GORDON, H.S., Growth of hybridoma cells in serum-free medium:ethanolamine is an essential component. Proc. nat. Acad. Sci. (Wash.), 79, 1158-1162 (1982).
29. NAGAO, K., MATSUZAKI, O., SAIGA, H., SUGANO, I., SHIGEMATSU, H., KANEKO, T., KATOH, T. and KITAMURA, T., Histopathologic studies on carcinoma in pleomorphic adenoma of the parotid gland. Cancer, 48, 113-121 (1981).
30. NANDA, R.R., ANDREW, R., MARK, E.F.S., IAN, B.K., WALTER, F.B., JULIAN, V.G. and DAVID, P.L., p53 mutations in colorectal cancer. Proc. nat. Acad. Sci. (Wash.), 87, 7555-7559 (1990).
31. OSBORN, L., HESSION, C., TIZARD, R., VASSALLO, C., LUHOWSKYL, S., CHI-ROSSO, G. and LOBB, R., Direct expression cloning of vascular cell adhesion molecule 1, a cytokine-induced endothelial protein that binds to lymphocytes. Cell, 59, 1203-1211 (1989).
32. PATHAK, S., Chromosome banding techniques. J. reprod. Med., 17, 25-28 (1976).
33. PETER, G., STEVEN, M.P., GARY, E.G., ZAHRA, M., ROSEMARIE, L., SATYA, P., SEN, P. and DONALD, F.P., Establishment and characterization of two new squamous-cell carcinoma cell lines derived from tumors of head and neck. Cancer Res., 48, 2858-2866 (1988).
34. ROWLEY, J.D., Mapping of human chromosomal regions related to neoplasia: evidence from chromosomes 1 and 17. Proc. nat. Acad. Sci. (Wash.), 74, 5729-5733 (1974).
35. SAKAI, E. and TSUCHIDA, N., Most human squamous-cell carcinomas in the oral cavity contain mutated p53 tumor-suppressor genes. Oncogene, 7, 927-933 (1992).
36. SAMBROOK, J., FRITSCH, E.F. and MANIATIS, T., Molecular cloning: a laboratory manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY (1989).
37. SCHOENMAKERS, E.F., KOOLS, P.F., MOLS, R., KAZMIERCZAK, B., BARTNIZKE, S., BULLERDIEK, J., DAL-CIN, P., DE JONG, P.J., VAN DEN BERGHE, H. and VAN DE VEN, W.J., Physical mapping of chromosome 12q breakpoints in lipoma, pleomorphic salivary gland adenoma, uterine leiomyoma and myxoid liposarcoma. Genomics, 20, 210-222 (1994).
38. SNIJDERS, P.J.F., CROMME, F.V., VANDENBRULE, A.J.C., SCHRIJNEMAKERS, H.F.J., SNOW, G.B., MEIJER, C.J.L.M. and WALBOOMERS, J.M.M., Prevalence and expression of human papillomavirus in tonsillar carcinomas, indicating a possible viral etiology. Int. J. Cancer, 51, 845-850 (1992).
39. SPANDIDOS, D.A., Mechanism of carcinogenesis: the role of oncogenes, transcriptional enhancers and growth factors. Anticancer Res., 5, 485-498 (1985).
40. THOMAS, P.S., Hybridization of denatured RNA and small DNA fragments transferred to nitrocellulose. Proc. nat. Acad. Sci. (Wash.), 77, 5201-5205 (1980).
41. VOGELSTEIN, B., FEARON, E.R., HAMILTON, S.R., KERN, S.E., PREISINGER, A.C., LEPPERT, M., NAKAMURA, Y., WHITE, R., SMITHS, A.M.M. and BOS, J.L., Genetic alterations during colorectal-tumor development. New Engl. J. Med., 319, 525-532 (1988).
42. YING, L., GIDEON, B., ROBIN, C., JEFF, S., LEACH, C., DAN, F., KEN, W., EITAN, F., WADA, S., MARGARET, R., PAIGE, B., FRANK, M., RAY, W. and RICHARD, C., Somatic mutations in the neurofibromatosis 1 gene in human tumors. Cell, 69, 275-281 (1992).
43. YOSHIKAWA, H., KAWANA, T., KITAGAWA, K., MIZUNO, M., YOSHIKURA, H. and IWAMOTO, A., Amplification and typing of multiple cervical cancer-associated human papillomavirus DNAs using a single pair of primers. Int. J. Cancer, 45, 990-992 (1990).